Evidence map›Paper›PMID 41598653›Full record

ArticleJournal of clinical medicine2026

Assessing Potential Valve-Preserving Effects of SGLT2 Inhibitors in Degenerative Aortic Stenosis: A Propensity-Matched Study.

Olivier Morel, Michael Guglieri, Antonin Trimaille, Benjamin Marchandot, Arnaud Bisson, Amandine Granier, Valérie Schini-Kerth, Anne Bernard, Laurent Fauchier

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Olivier MorelDepartment of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, 67098 Strasbourg, France.ORCID 0000-0002-7295-3041
Michael GuglieriService de Cardiologie, Centre Hospitalier Universitaire Trousseau et Faculté de Médecine, Université François Rabelais, 37000 Tours, France.
Antonin TrimailleDepartment of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, 67098 Strasbourg, France.
Benjamin MarchandotDepartment of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, 67098 Strasbourg, France.ORCID 0000-0001-7034-1466
Arnaud BissonService de Cardiologie, Centre Hospitalier Universitaire Trousseau et Faculté de Médecine, Université François Rabelais, 37000 Tours, France.
Amandine GranierDepartment of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, 67098 Strasbourg, France.
Valérie Schini-KerthUR 3074 Translational Cardiovascular Medicine, CRBS, University of Strasbourg, 67000 Strasbourg, France.ORCID 0000-0001-9997-9287
Anne BernardService de Cardiologie, Centre Hospitalier Universitaire Trousseau et Faculté de Médecine, Université François Rabelais, 37000 Tours, France.
Laurent FauchierService de Cardiologie, Centre Hospitalier Universitaire Trousseau et Faculté de Médecine, Université François Rabelais, 37000 Tours, France.ORCID 0000-0002-9267-1658

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

aortic valvedapaglifozindegenerative aortic stenosisempaglifozingliflozinsSAVRTAVITAVR

Identifiers

PMID41598653
PMCPMC12842084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.